Hui Wang

Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial

Huabin Hu, Liang Kang, Jianwei Zhang et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 278 citations

Neoadjuvant Pd-1 Blockade, Medicine, Immunology +7

<scp><i>NTRK</i></scp> fusion positive colorectal cancer is a unique subset of <scp>CRC</scp> with high <scp>TMB</scp> and microsatellite instability

Hui Wang, Zhiwei Li, Qiuxiang Ou et al. · Cancer Medicine · 2022 · 63 citations · Full text

Cancer Pathology, Genetics, Immunology +17

Formation of Polyploid Giant Cancer Cells Involves in the Prognostic Value of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer

Fei Fei, Mingqing Zhang, Bo Li et al. · Journal of Oncology · 2019 · 52 citations · Full text

Comparison of Clinical Characteristics Between Benign Borderline and Malignant Phyllodes Tumors of the Breast

Hui Wang, Xiang Wang, Chengfeng Wang · Asian Pacific Journal of Cancer Prevention · 2015 · 30 citations · Full text

Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China.

Qiuhua Deng, Haihong Yang, Yongping Lin et al. · PubMed · 2014 · 26 citations · Full text